Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.

Gallagher A, Butler TJ, Home PD.

Diabetes Res Clin Pract. 2007 Jun;76(3):327-34. Epub 2006 Nov 7.

PMID:
17092597
2.
3.

When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?

Raccah D, Bretzel RG, Owens D, Riddle M.

Diabetes Metab Res Rev. 2007 May;23(4):257-64. Review.

PMID:
17315242
4.

Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.

Raccah D.

Diabetes Obes Metab. 2008 Jul;10 Suppl 2:76-82. doi: 10.1111/j.1463-1326.2008.00846.x. Review.

PMID:
18577159
5.

Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.

Kinsley B.

Clin Ther. 2007;29 Suppl D:S153-60. doi: 10.1016/j.clinthera.2007.12.015. Review.

PMID:
18191067
6.

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.

Cucinotta D, Russo GT.

Expert Opin Pharmacother. 2009 Dec;10(17):2905-11. doi: 10.1517/14656560903391714. Review.

PMID:
19929709
7.

Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.

Rossetti P, Porcellati F, Fanelli CG, Perriello G, Torlone E, Bolli GB.

Arch Physiol Biochem. 2008 Feb;114(1):3-10. doi: 10.1080/13813450801900777 . Review.

PMID:
18465353
8.

New insulins in the treatment of diabetes mellitus.

Lindholm A.

Best Pract Res Clin Gastroenterol. 2002 Jun;16(3):475-92. Review.

PMID:
12079270
9.

Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.

Robertson C.

Diabetes Educ. 2006 May-Jun;32(3):423-32. Review.

PMID:
16772658
10.

A review of human and analogue insulin trials.

Gough SC.

Diabetes Res Clin Pract. 2007 Jul;77(1):1-15. Epub 2006 Nov 16. Review.

PMID:
17112621
11.

Dosing of insulin glargine in the treatment of type 2 diabetes.

Barnett A.

Clin Ther. 2007 Jun;29(6):987-99. Review.

PMID:
17692716
12.

Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis.

Mannucci E, Monami M, Marchionni N.

Diabetes Obes Metab. 2009 Jan;11(1):53-9. doi: 10.1111/j.1463-1326.2008.00934.x. Epub 2008 Jul 29. Review.

PMID:
18671795
13.

Premixed insulin treatment for type 2 diabetes: analogue or human?

Garber AJ, Ligthelm R, Christiansen JS, Liebl A.

Diabetes Obes Metab. 2007 Sep;9(5):630-9. Review.

PMID:
17697056
14.

Early-phase prandial insulin secretion: its role in the pathogenesis of type 2 diabetes mellitus and its modulation by repaglinide.

Owens DR, Cozma LS, Luzio SD.

Diabetes Nutr Metab. 2002 Dec;15(6 Suppl):19-27. Review.

PMID:
12702004
15.

Reducing hypoglycaemia with insulin analogues.

Heller S.

Int J Obes Relat Metab Disord. 2002 Sep;26 Suppl 3:S31-6. Review.

PMID:
12174321
16.

Rapid-acting insulin secretagogues: a clinical need?

Home PD.

Exp Clin Endocrinol Diabetes. 1999;107 Suppl 4:S115-9. Review.

PMID:
10522834
17.

Loss of early insulin secretion leads to postprandial hyperglycaemia.

Del Prato S.

Diabetologia. 2003 Mar;46 Suppl 1:M2-8. Epub 2002 Nov 12. Review.

PMID:
12652352
18.

Insulin aspart: a review.

Owens D, Vora J.

Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):793-804. Review.

PMID:
17014395
19.

[The new insulins].

Krzentowski G.

Rev Med Brux. 2005 Sep;26(4):S241-5. Review. French.

PMID:
16240869

Supplemental Content

Support Center